Novartis MF59®-adjuvanted Vaccine Rapidly Induces Protective Antibody Levels Against Diverse Strains Of Avian Flu
Sep 30th 2008Drug InformationBird Flu
A new study shows that individuals immunized six years earlier with an MF59 adjuvanted H5N3 (clade 0) vaccine mounted a protective immune response seven days after a single immunization with an H5N1 (clade 1) vaccine containing the Novartis proprietary adjuvant MF59. The immune response was broadly cross reactive and covered all H5N1 clades known to date. These data were presented at the Third European Influenza Conference in Vilamoura, Portugal.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
